Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Squamous Cell Tumors × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8579 Neoplasms 6592 Carcinoma, Non-Small-Cell Lung 4814 Prostatic Neoplasms 4255 Colorectal Neoplasms 3852 Lung Neoplasms 3105 Leukemia, Myeloid, Acute 2620 Neoplasm Metastasis 2609 Multiple Myeloma 2594 Pancreatic Neoplasms 2423 Melanoma 2236 Ovarian Neoplasms 2184 Lymphoma 2179 Carcinoma, Hepatocellular 2088 Stomach Neoplasms 1976 Recurrence 1874 Head and Neck Neoplasms 1762 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1750 Lymphoma, Non-Hodgkin 1734 Leukemia 1723 Brain Neoplasms 1633 Glioblastoma 1528 Colonic Neoplasms 1504 Leukemia, Lymphocytic, Chronic, B-Cell 1476 Rectal Neoplasms 1456 Uterine Cervical Neoplasms 1400 Lymphoma, Follicular 1377 Squamous Cell Carcinoma of Head and Neck 1373 Lymphoma, Large B-Cell, Diffuse 1351 Carcinoma, Renal Cell 1312

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01741727 2017-11-20

A Study of ABT-414 in Subjects With Solid Tumors

AbbVie

Phase 1 Completed

Squamous Cell Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡